Bedrijfsoverzicht
Ardent Health, Inc. owns and operates an extensive network of hospitals and clinics that delivers a comprehensive range of healthcare services throughout the United States. The organization functions within the Healthcare sector, specifically classified under the Medical Care Facilities industry, positioning it as a significant provider of both general and specialty medical care including internal medicine, surgery, cardiology, oncology, and orthopedics. This enterprise employs approximately 19,500 individuals and maintains a substantial market capitalization of $1.35 billion, reflecting its established presence in the market. With annual revenue reaching $6.32 billion, the company demonstrates a large-scale operational footprint that suggests it plays a pivotal role in the domestic healthcare infrastructure. The combination of a multi-billion dollar revenue base and a workforce of nearly twenty thousand employees indicates that Ardent Health is a major player capable of influencing regional healthcare delivery standards.
Financiële gezondheid
Ardent Health, Inc. reported a trailing twelve-month revenue of $6.32 billion, generating a net income of $135.81 million and an EBITDA of $481.29 million. The considerable disparity between the $6.32 billion in revenue and the $135.81 million in net income highlights a significant cost structure where operating expenses, including salaries, supplies, and overhead, consume approximately 97.9% of total revenue before accounting for interest and taxes. The company generated $155.97 million in free cash flow, which provides essential financial flexibility for capital expenditures, debt servicing, or potential strategic acquisitions without relying solely on external financing. Operational efficiency is evidenced by a gross margin of 58.0%, which indicates strong pricing power or favorable input costs relative to the cost of services rendered. However, the operating margin stands at 6.5% and the profit margin is further compressed to 2.1%, suggesting high fixed costs inherent to the hospital industry that limit the pass-through of gross profitability to the bottom line. On the balance sheet, the company holds $712.49 million in cash against total debt of $2.32 billion, resulting in a debt-to-equity ratio of 137.57 which characterizes a highly leveraged capital structure typical of asset-heavy healthcare providers. Despite the high debt load, a current ratio of 1.97 indicates robust short-term liquidity, ensuring the entity can comfortably meet its obligations due within one year. Management effectiveness is further illuminated by a return on equity of 14.4% and a return on assets of 4.0%, where the former suggests efficient use of shareholder capital while the latter reflects the challenging return environment faced by capital-intensive medical facilities.
Waarderingsbeoordeling
The stock trades with a trailing twelve-month P/E ratio of 9.79 and a forward P/E of 8.06, implying that the market anticipates an improvement in earnings per share as the forward multiple is lower than the historical average. The price-to-book ratio is recorded at 1.04, indicating that the market values the company's equity at a level roughly equivalent to its book value, rather than applying a significant premium or discount. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.21 and an EV/EBITDA of 6.95, suggesting the company is valued at a fraction of its revenue stream relative to its earnings before interest, taxes, depreciation, and amortization. Regarding price volatility, the 52-week high is $15.48 and the 52-week low is $8.07; however, the current trading price relative to this specific range cannot be precisely calculated without the exact current share price, though the forward P/E discount hints at potential mean reversion expectations. The beta value is listed as N/A, meaning that specific volatility data relative to the broader market index is not disclosed in the available data points. These valuation multiples collectively present a picture of a company trading at earnings and sales multiples that are generally consistent with mature healthcare operators facing cyclical headwinds.
Growth & Income
Revenue growth year-over-year is recorded at -0.1%, while earnings growth year-over-year has declined significantly to -60.6%, indicating that earnings are contracting at a much faster rate than revenue, which points to margin compression or one-time cost increases affecting profitability. The company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which signifies that the organization retains all of its earnings rather than distributing them to shareholders. This retention strategy suggests that management prioritizes reinvesting capital into operations, debt reduction, or business expansion over providing immediate income to investors. The overall growth and income profile for Ardent Health, Inc. is currently characterized by flat revenue performance and a sharp contraction in earnings, with no distribution of income to shareholders, reflecting a period of financial consolidation or strategic restructuring within the healthcare landscape.